ORMDL3 and asthma: From these findings, we might hypothesize that in patients carrying 17q12–21 asthma risk SNPs, dynamic changes in the expression and action of key ER SERCA pumps in response to T cell receptor (TCR) activation would be hindered by higher ORMDL3 expression in CD4+ T cells.